SCHEMBL12033729

SCHEMBL12033729

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-n4c5ccc(-n6c7ccccc7c7ccccc76)cc5c5cc(-n6c7ccccc7c7ccccc76)ccc54)n3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.43
▸ ATM Q13315 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ RAC2 P15153 1/20 0.41
▸ RAC3 P60763 1/20 0.41
▸ CDC42 P60953 1/20 0.41
▸ RAC1 P63000 1/20 0.41
▸ KMT2A Q03164 5/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ MAPT P10636 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ PTGER4 P35408 1/20 0.35
▸ NR3C1 P04150 1/20 0.35
▸ EDNRB P24530 1/20 0.35
▸ EDNRA P25101 1/20 0.35
▸ NPY5R Q15761 1/20 0.35
▸ TSPO P30536 1/20 0.34
▸ NTSR1 P30989 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15371700 1.00 KDM4E (0.43) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL16152684 1.00 KDM4E (0.43) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL15606637 1.00 KDM4E (0.43) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL12033836 0.97 ATM (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL12033748 0.97 ATM (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL16689516 0.97 ATM (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL12033591 0.97 ATM (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL12033843 0.97 ATM (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL24677419 0.97 L3MBTL1 (0.47) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL16233985 0.97 KDM4E (0.43) KDM4EATML3MBTL1RAC2RAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110309345-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE HAVING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2011-12-22 — — US disclosed
US-20110309345-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE HAVING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2011-12-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110309345-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE HAVING THE SAME ARL1, MCOLN2, NAT1 KDM4E 2017/4885ATM 1414/4885L3MBTL1 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback